Hypoxia-inducible factor-1α overexpression indicates poor clinical outcomes in tongue squamous cell carcinoma

Experimental and Therapeutic Medicine

Volumn 5, Issue 1, 2013, Pages 112-118

  Kang, Fei Wu ^a   Gao, Yin ^b   Que, Lin ^a   Sun, Jing ^a   Wang, Zuo Lin ^a  

^a TONGJI UNIVERSITY   (China)

^b WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Hypoxia; Hypoxia inducible factor 1 ; Prognosis; Tongue squamous cell carcinoma; Vascular endothelial growth factor

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER PROGNOSIS; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; TISSUE DIFFERENTIATION; TONGUE CARCINOMA; TREATMENT OUTCOME;

EID: 84869433019     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.779     Document Type: Article

References (31)

1. Hochachka PW: Mechanism and evolution of hypoxia-tolerance in humans. J Exp Biol 201: 1243-1254, 1998.
2. Vaupel P, Thews O and Hoeckel M: Treatment resistance of solid tumors: role of hypoxia and anemia. Med Oncol 18: 243-259, 2001.
3. Nakayama K, Kanzaki A, Hata K, et al: Hypoxia-inducible factor 1 alpha (HIF-1 alpha) gene expression in human ovarian carcinoma. Cancer Lett 176: 215-223, 2002.
4. Kuwai T, Kitadai Y, Tanaka S, et al: Expression of hypoxia-inducible factor-1alpha is associated with tumor vascu-larization in human colorectal carcinoma. Int J Cancer 105: 176-181, 2003.
5. Ioannou M, Mylonis I, Kouvaras E, et al: Validated analysis of HIF-1α expression in cancer cells using a controlled and comparative immunoassay. Oncol Rep 24: 161-169, 2010.
6. Wang GL, Jiang BH, Rue EA and Semenza GL: Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 92: 5510-5514, 1995.
7. Salceda S and Caro J: Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiq-uitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J Biol Chem 272: 22642-22647, 1997.
8. Wang GL and Semenza GL: General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci USA 90: 4304-4308, 1993.
9. Krieg M, Haas R, Brauch H, Acker T, Flamme I and Plate KH: Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Oncogene 19: 5435-5443, 2000.
10. Iliopoulos O, Levy AP, Jiang C, Kaelin WG Jr and Goldberg MA: Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc Natl Acad Sci USA 93: 10595-10599, 1996.
11. Bianco F, Basini G, Santini S and Grasselli F: Angiogenic activity of swine granulosa cells: effects of hypoxia and the role of VEGF. Vet Res Commun 29 (Suppl 2): 157-159, 2005.
12. Choi SB, Park JB, Song TJ and Choi SY: Molecular mechanism of HIF-1-independent VEGF expression in a hepatocellular carcinoma cell line. Int J Mol Med 28: 449-454, 2011.
13. Yasuda S, Arii S, Mori A, et al: Hexokinase II and VEGF expression in liver tumors: correlation with hypoxia-inducible factor 1 alpha and its significance. J Hepatol 40: 117-123, 2004.
14. Takahashi R, Tanaka S, Hiyama T, et al: Hypoxia-inducible factor-1α expression and angiogenesis in gastrointestinal stromal tumor of the stomach. Oncol Rep 10: 797-802, 2003.
15. Giatromanolaki A, Koukourakis MI, Sivridis E, et al: Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profle of tumours and survival. Br J Cancer 85: 881-890, 2001.
16. Casiglia J and Woo SB: A comprehensive review of oral cancer. Gen Dent 49: 72-82, 2001.
17. Wittekind C, Compton CC, Greene FL and Sobin LH: TNM residual tumor classification revisited. Cancer 94: 2511-2516, 2002.
18. Gordan JD and Simon MC: Hypoxia-inducible factors: central regulators of the tumor phenotype. Curr Opin Genet Dev 17: 71-77, 2007.
19. Semenza GL: Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit Rev Biochem Mol Biol 35: 71-103, 2000.
20. Semenza GL: Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3: 721-732, 2003.
21. Richard DE, Berra E and Pouysségur J: Angiogenesis: how a tumor adapts to hypoxia. Biochem Biophys Res Commun 266: 718-722, 1999.
22. Kyzas PA, Stefanou D, Batistatou A and Agnantis NJ: Prognostic significance of VEGF immunohistochemical expression and tumor angiogenesis in head and neck squamous cell carcinoma. J Cancer Res Clin Oncol 131: 624-630, 2005.
23. Vidal O, Soriano-Izquierdo A, Pera M, et al: Positive VEGF immu-nostaining independently predicts poor prognosis in curatively resected gastric cancer patients: results of a study assessing a panel of angiogenic markers. J Gastrointest Surg 12: 1005-1014, 2008.
24. Zhao ZQ, Yang S and Lu HS: Expression of midkine and vascular endothelial growth factor in gastric cancer and the association of high levels with poor prognosis and survival. Mol Med Report 5: 415-419, 2012.
25. Sugiura T, Inoue Y, Matsuki R, et al: VEGF-C and VEGF-D expression is correlated with lymphatic vessel density and lymph node metastasis in oral squamous cell carcinoma: Implications for use as a prognostic marker. Int J Oncol 34: 673-680, 2009.
26. Shibaji T, Nagao M, Ikeda N, et al: Prognostic significance of HIF-1 alpha overexpression in human pancreatic cancer. Anticancer Res 23: 4721-4727, 2003.
27. Gruber G, Greiner RH, Hlushchuk R, et al: Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter? Breast Cancer Res 6: R191-R198, 2004.
28. Lu XG, Xing CG, Feng YZ, Chen J and Deng C: Clinical significance of immunohistochemical expression of hypoxia-inducible factor-1alpha as a prognostic marker in rectal adenocarcinoma. Clin Colorectal Cancer 5: 350-353, 2006.
29. Birner P, Schindl M, Obermair A, Plank C, Breitenecker G and Oberhuber G: Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res 60: 4693-4696, 2000.
30. Bos R, van der Groep P, Greijer AE, et al: Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer 97: 1573-1581, 2003.
31. Fillies T, Werkmeister R, van Diest PJ, Brandt B, Joos U and Buerger H: HIF1-alpha overexpression indicates a good prognosis in early stage squamous cell carcinomas of the oral foor. BMC Cancer 5: 84, 2005.